Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant

R. A. Bowden, S. J. Slichter, M. H. Sayers, M. Mori, M. J. Cays, J. D. Meyers

Research output: Contribution to journalArticlepeer-review

175 Scopus citations

Fingerprint

Dive into the research topics of 'Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds